SpaceX lowballed its bankers on fees. Goldman Sachs has another way to win big

SpaceX’s planned IPO is targeting a $75 billion primary raise at $135 per share, with the full deal potentially reaching just over $86 billion including the 15% over-allotment. At a 0.75% gross spread, banks would split roughly $646 million in fees, but the bigger prize may be more than $5 billion in first-day soft dollars if the stock pops 20% to $162. Goldman Sachs is positioned to capture the largest share of both fees and share allocation control as lead-left underwriter.

Analysis

This is less a story about IPO economics than about who captures the economics of scarcity. When supply is fixed and demand is forced through a narrow distribution funnel, the lead allocator gets the real option value: information flow, client retention, and repeated soft-dollar monetization. That makes GS the cleanest beneficiary, with MS a secondary winner, while the retail-centric brokers (SCHW, NDAQ-adjacent venues, and smaller syndicate members) get fee crumbs but little control over where the highest-conviction order flow lands.

The second-order effect is that a massive, marquee allocation event should tighten the relationship between elite growth issuers and the handful of banks that can place them. That is bullish for capital-markets revenue over the next 2 quarters, but also for secondary trading desks and prime brokerage if the deal pops and hedged clients recycle profits into more trading. The flip side is that if the aftermarket is weak, the same institutions that were promised scarcity value can quickly become sources of de-risking, pressuring the very banks that appear to have won the mandate.

The market is likely underestimating how much this feeds into a broader AI IPO pipeline. The real catalyst is not one deal but the signaling effect: a successful float at a premium valuation validates the pricing ladder for other private AI assets, which could lift expectations for MS, GS, and the broader underwriting complex over the next 3-6 months. The contrarian risk is that an overheated first-day print invites political and regulatory scrutiny around allocation practices and underpricing, which can cap the durability of the fee narrative even if the headline economics stay intact.

The clearest tactical edge is in relative value, not outright beta. GS should outperform peers if this deal translates into trading and allocation alpha, but the risk/reward improves only if the stock holds its initial bid and client activity follows through in Q2/Q3. A weak aftermarket would still leave the fee pool intact, but it would sharply reduce the soft-dollar halo and could unwind the market’s current willingness to pay up for the franchise.

Key Decisions for Investors

• Long GS vs. XLF or equal-weighted large-cap bank basket for 1-3 months; thesis is lead-allocator control plus soft-dollar monetization, with upside from secondary trading spillover and limited downside unless the IPO falters materially.
• Long MS vs. C over the next quarter; MS participates in the institutional book and should capture a meaningful share of the revenue lift, while C has less franchise leverage to the high-touch allocation channel.
• Buy a short-dated GS call spread into pricing/first-day trading, sized as a catalyst trade; best risk/reward if the stock pops and Street revises capital-markets revenue expectations higher for 1H.
• Pair long GS / short SCHW for 4-8 weeks; if allocations drive outsized soft-dollar flow, the benefit accrues to the lead underwriter far more than the retail distribution platforms.
• If the stock weakens post-launch, fade the move by reducing GS exposure rather than selling the entire bank complex; the long-term underwriting signal remains positive unless subsequent AI deal flow stalls.